Lyra Therapeutics (LYRA) Leases (2019 - 2025)
Quarterly Leases fell 15.72% to $16.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.8 million through Dec 2025, down 15.72% year-over-year, with the annual reading at $16.8 million for FY2025, 15.72% down from the prior year.
Lyra Therapeutics' Leases history spans 7 years, with the latest figure at $16.8 million for Q4 2025.
- Leases came in at $16.8 million for Q4 2025, down from $17.6 million in the prior quarter.
- In the past five years, Leases ranged from a high of $45.6 million in Q1 2024 to a low of $608000.0 in Q3 2022.
- The 5-year median for Leases is $4.1 million (2022), against an average of $11.7 million.
- Year-over-year, Leases plummeted 61.9% in 2022 and then skyrocketed 2400.05% in 2024.
- Lyra Therapeutics' Leases stood at $1.4 million in 2021, then skyrocketed by 64.06% to $2.2 million in 2022, then surged by 1394.96% to $33.2 million in 2023, then tumbled by 40.05% to $19.9 million in 2024, then fell by 15.72% to $16.8 million in 2025.
- Per Business Quant, the three most recent readings for LYRA's Leases are $16.8 million (Q4 2025), $17.6 million (Q3 2025), and $18.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Lyra Therapeutics | - | - | - | 16.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.79 Mn |
| Sep 30, 2025 | 17.58 Mn |
| Jun 30, 2025 | 18.36 Mn |
| Mar 31, 2025 | 19.14 Mn |
| Dec 31, 2024 | 19.92 Mn |
| Sep 30, 2024 | 20.71 Mn |
| Jun 30, 2024 | 21.49 Mn |
| Mar 31, 2024 | 45.63 Mn |
| Dec 31, 2023 | 33.23 Mn |
| Sep 30, 2023 | 6.07 Mn |
| Jun 30, 2023 | 1.42 Mn |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 2.22 Mn |
| Sep 30, 2022 | 608,000.00 |
| Jun 30, 2022 | 860,000.00 |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 1.36 Mn |
| Sep 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 1.83 Mn |
| Mar 31, 2021 | 2.07 Mn |
| Dec 31, 2020 | 2.30 Mn |
| Sep 30, 2020 | 2.53 Mn |
| Jun 30, 2020 | 2.76 Mn |
| Mar 31, 2020 | 2.96 Mn |
| Dec 31, 2019 | 3.18 Mn |